Form 4: Lemaitre Vascular Director Jasinski Reports Acquisition of Dividend Equivalent Rights
SEC Form 4 Filing
Director Lawrence J. Jasinski reports the acquisition of dividend equivalent rights related to restricted stock units and performance stock units.
Summary
- On March 27, 2025, Lawrence J. Jasinski, a director of Lemaitre Vascular Inc., reported the acquisition of dividend equivalent rights.
- These rights are associated with restricted stock unit (RSU) and performance stock unit (PSU) awards previously granted.
- The dividend equivalent rights vest proportionately with the underlying RSU and PSU awards.
- The acquired rights are the economic equivalent of common stock shares.
- The acquisitions are related to awards granted on December 12, 2022, December 8, 2023, and December 6, 2024.
- The total dividend equivalent rights acquired are 0.4803, 0.4803, 0.8214, 0.9838 and 1.001.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing regarding the acquisition of dividend equivalent rights, which is neither particularly positive nor negative.
Industry Context
This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies.
Stakeholder Impact
- The acquisition of dividend equivalent rights has a minor impact on shareholders as it relates to executive compensation.
Key Dates
| Date | Description |
|---|---|
| 12/12/2022 | Date of grant for restricted stock unit and performance stock unit awards related to dividend equivalent rights. |
| 12/08/2023 | Date of grant for restricted stock unit and performance stock unit awards related to dividend equivalent rights. |
| 12/06/2024 | Date of grant for restricted stock unit award related to dividend equivalent rights. |
| 03/27/2025 | Date of transaction: Acquisition of dividend equivalent rights. |
| 03/31/2025 | Date of signature for the Form 4 filing. |
Keywords
dividend equivalent rights, Lemaitre Vascular, director, Jasinski, LMAT, Form 4, RSU, PSU, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.